Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$173,234,097
+$39,720,991 QoQ
Shares Held
6,606,945
+16.6% QoQ
Ownership
5.26%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#5
of 270 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. ARQT ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,234,097 | 6,606,945 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $173,234,097 | 6,606,945 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $133,513,106 | 5,666,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $161,351,147 | 5,556,169 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $99,881,512 | 5,298,754 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $70,190,779 | 5,006,475 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $104,889,269 | 6,706,475 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $104,889,269 | 6,706,475 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $102,766,917 | 7,377,381 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $64,024,659 | 6,884,372 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $63,975,369 | 6,879,072 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $68,239,487 | 6,885,922 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,341,532 | 6,297,688 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,556,282 | 3,117,944 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $29,807,714 | 3,127,777 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $34,490,643 | 3,135,513 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $29,685,499 | 2,005,777 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,020,111 | 1,309,268 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,957,512 | 1,405,796 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $34,359,936 | 1,784,005 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $37,000,263 | 1,784,005 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,003,244 | 1,548,901 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,916,598 | 1,682,543 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $45,059,718 | 1,557,543 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,800,750 | 775,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||